As of 2025-04-23, the Relative Valuation of Brooklyn Immunotherapeutics Inc (BTX) is (26,845.52) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.85 USD, the upside of Brooklyn Immunotherapeutics Inc based on Relative Valuation is -458997.8%.
The range of the Relative Valuation is (25,067.61) - (31,011.66) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 28.3x - 36.2x | 30.8x |
| Forward P/E multiples | 26.1x - 35.1x | 29.8x |
| Fair Price | (25,067.61) - (31,011.66) | (26,845.52) |
| Upside | -428606.2% - -530213.9% | -458997.8% |
| Date | P/E |
| 2025-04-21 | -0.01 |
| 2025-04-17 | -0.01 |
| 2025-04-16 | -0.01 |
| 2025-04-15 | -0.01 |
| 2025-04-14 | -0.01 |
| 2025-04-11 | -0.01 |
| 2025-04-10 | -0.01 |
| 2025-04-09 | -0.01 |
| 2025-04-08 | -0.01 |
| 2025-04-07 | -0.01 |
| 2025-04-04 | -0.01 |
| 2025-04-03 | -0.01 |
| 2025-04-02 | -0.01 |
| 2025-04-01 | -0.01 |
| 2025-03-31 | -0.01 |
| 2025-03-28 | -0.01 |
| 2025-03-27 | -0.01 |
| 2025-03-26 | -0.01 |
| 2025-03-25 | -0.01 |
| 2025-03-24 | -0.01 |
| 2025-03-21 | -0.01 |
| 2025-03-20 | -0.01 |
| 2025-03-19 | -0.01 |
| 2025-03-18 | -0.01 |
| 2025-03-17 | -0.01 |
| 2025-03-14 | -0.01 |
| 2025-03-13 | -0.01 |
| 2025-03-12 | -0.01 |
| 2025-03-11 | -0.01 |
| 2025-03-10 | -0.01 |
| 2025-03-07 | -0.01 |
| 2025-03-06 | -0.01 |
| 2025-03-05 | -0.01 |
| 2025-03-04 | -0.01 |
| 2025-03-03 | -0.01 |
| 2025-02-28 | -0.01 |
| 2025-02-27 | -0.01 |
| 2025-02-26 | -0.01 |
| 2025-02-25 | -0.01 |
| 2025-02-24 | -0.01 |
| 2025-02-21 | -0.01 |
| 2025-02-20 | -0.01 |